|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2022
As of Aug 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash | ||||||||||||
| Restricted cash | ||||||||||||
| Accounts receivable, net | ||||||||||||
| Digital assets | ||||||||||||
| Contingent consideration, current | ||||||||||||
| Fair market value share price | ||||||||||||
| Government remittances | ||||||||||||
| Promissory note receivable, current | ||||||||||||
| Prepaid expenses and other current assets | ||||||||||||
| Total current assets | ||||||||||||
| Investments | ||||||||||||
| Contingent consideration, non-current | ||||||||||||
| Investment in ETH fund | ||||||||||||
| Promissory note receivable, non-current | ||||||||||||
| Property and equipment, net | ||||||||||||
| Goodwill | ||||||||||||
| Intangible assets, definite lived, net | ||||||||||||
| Intangible assets, indefinite lived | ||||||||||||
| Right-of-use assets | ||||||||||||
| Total assets | ||||||||||||
| Liabilities, Mezzanine Equity and Shareholders’ Equity | ||||||||||||
| Accounts payable | ||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||
| Players liability account | ||||||||||||
| Deferred revenue | ||||||||||||
| Current portion of operating lease liability | ||||||||||||
| Line of credit | ||||||||||||
| Promissory notes payable, current | ||||||||||||
| Convertible debt carried at fair value, current | ||||||||||||
| Warrant liability | ||||||||||||
| Contingent purchase consideration, current | ||||||||||||
| Deferred purchase consideration | ||||||||||||
| Arbitration reserve | ||||||||||||
| Total current liabilities | ||||||||||||
| Convertible debt carried at fair value, non-current | ||||||||||||
| Contingent purchase consideration, non-current | ||||||||||||
| Deferred tax liability | ||||||||||||
| Operating lease liability | ||||||||||||
| Total liabilities | ||||||||||||
| Mezzanine equity | ||||||||||||
| Series A-3 Redeemable Convertible Preferred Stock | ||||||||||||
| Total Mezzanine equity | ||||||||||||
| Series A-1 convertible preferred stock ($0.0001 par value, 50,000,000 authorized, 0 and 3,433 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively) | ||||||||||||
| Series A-1 Convertible Preferred Stock | ||||||||||||
| Total series A-1 convertible preferred stock ($0.0001 par value, 50,000,000 authorized, 0 and 3,433 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively) | ||||||||||||
| Common stock ($0.0001 par value, 500,000,000 shares authorized, 102,371,390 and 98,066,751 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively) | ||||||||||||
| Additional paid-in capital | ||||||||||||
| Treasury stock | ||||||||||||
| Accumulated other comprehensive loss | ||||||||||||
| Non-controlling interest | ||||||||||||
| Accumulated deficit | ||||||||||||
| Total shareholders’ equity | ||||||||||||
| Total liabilities and shareholders’ equity | ||||||||||||
Loading...